vs

Side-by-side financial comparison of CS Disco, Inc. (LAW) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $41.2M, roughly 1.8× CS Disco, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 11.3%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $255.0K). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 7.6%).

CS Disco, Inc. is a leading legal technology provider that develops cloud-based software solutions for legal practitioners. Its core offerings include e-discovery, document review, case management, and legal workflow automation tools, serving law firms, corporate legal teams, and government legal departments primarily in North America.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

LAW vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.8× larger
PBYI
$75.5M
$41.2M
LAW
Growing faster (revenue YoY)
PBYI
PBYI
+16.4% gap
PBYI
27.7%
11.3%
LAW
More free cash flow
PBYI
PBYI
$14.1M more FCF
PBYI
$14.4M
$255.0K
LAW
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
7.6%
LAW

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LAW
LAW
PBYI
PBYI
Revenue
$41.2M
$75.5M
Net Profit
$-8.5M
Gross Margin
75.1%
69.3%
Operating Margin
-22.4%
22.7%
Net Margin
-20.7%
Revenue YoY
11.3%
27.7%
Net Profit YoY
66.3%
EPS (diluted)
$-0.13
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LAW
LAW
PBYI
PBYI
Q4 25
$41.2M
$75.5M
Q3 25
$40.9M
$54.5M
Q2 25
$38.1M
$52.4M
Q1 25
$36.7M
$46.0M
Q4 24
$37.0M
$59.1M
Q3 24
$36.3M
$80.5M
Q2 24
$36.0M
$47.1M
Q1 24
$35.6M
$43.8M
Net Profit
LAW
LAW
PBYI
PBYI
Q4 25
$-8.5M
Q3 25
$-13.7M
$8.8M
Q2 25
$-10.8M
$5.9M
Q1 25
$-11.4M
$3.0M
Q4 24
$-25.2M
Q3 24
$-9.2M
$20.3M
Q2 24
$-10.8M
$-4.5M
Q1 24
$-10.6M
$-4.8M
Gross Margin
LAW
LAW
PBYI
PBYI
Q4 25
75.1%
69.3%
Q3 25
75.5%
77.7%
Q2 25
74.6%
76.5%
Q1 25
74.1%
77.1%
Q4 24
74.2%
76.4%
Q3 24
73.1%
63.9%
Q2 24
74.2%
77.4%
Q1 24
75.1%
75.5%
Operating Margin
LAW
LAW
PBYI
PBYI
Q4 25
-22.4%
22.7%
Q3 25
-35.3%
17.6%
Q2 25
-31.0%
12.7%
Q1 25
-34.4%
8.7%
Q4 24
-70.6%
22.6%
Q3 24
-30.0%
27.4%
Q2 24
-34.4%
-4.6%
Q1 24
-34.7%
-5.3%
Net Margin
LAW
LAW
PBYI
PBYI
Q4 25
-20.7%
Q3 25
-33.4%
16.2%
Q2 25
-28.4%
11.2%
Q1 25
-31.1%
6.5%
Q4 24
-68.1%
Q3 24
-25.3%
25.2%
Q2 24
-30.1%
-9.6%
Q1 24
-29.7%
-11.0%
EPS (diluted)
LAW
LAW
PBYI
PBYI
Q4 25
$-0.13
$0.26
Q3 25
$-0.22
$0.17
Q2 25
$-0.18
$0.12
Q1 25
$-0.19
$0.06
Q4 24
$-0.43
$0.40
Q3 24
$-0.15
$0.41
Q2 24
$-0.18
$-0.09
Q1 24
$-0.17
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LAW
LAW
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$114.6M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$128.1M
$130.3M
Total Assets
$173.6M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LAW
LAW
PBYI
PBYI
Q4 25
$114.6M
$97.5M
Q3 25
$113.5M
$94.4M
Q2 25
$114.5M
$96.0M
Q1 25
$118.8M
$93.2M
Q4 24
$129.1M
$101.0M
Q3 24
$126.8M
$96.7M
Q2 24
$130.0M
$96.8M
Q1 24
$148.7M
$107.2M
Total Debt
LAW
LAW
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
LAW
LAW
PBYI
PBYI
Q4 25
$128.1M
$130.3M
Q3 25
$130.6M
$115.3M
Q2 25
$137.9M
$104.7M
Q1 25
$142.2M
$97.1M
Q4 24
$147.5M
$92.1M
Q3 24
$167.3M
$71.1M
Q2 24
$170.9M
$48.5M
Q1 24
$193.2M
$51.0M
Total Assets
LAW
LAW
PBYI
PBYI
Q4 25
$173.6M
$216.3M
Q3 25
$174.8M
$202.9M
Q2 25
$164.9M
$194.9M
Q1 25
$168.0M
$196.2M
Q4 24
$180.3M
$213.3M
Q3 24
$194.4M
$220.7M
Q2 24
$198.0M
$205.0M
Q1 24
$217.3M
$214.1M
Debt / Equity
LAW
LAW
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LAW
LAW
PBYI
PBYI
Operating Cash FlowLast quarter
$762.0K
$14.4M
Free Cash FlowOCF − Capex
$255.0K
$14.4M
FCF MarginFCF / Revenue
0.6%
19.1%
Capex IntensityCapex / Revenue
1.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-18.0M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LAW
LAW
PBYI
PBYI
Q4 25
$762.0K
$14.4M
Q3 25
$-979.0K
$9.7M
Q2 25
$-4.2M
$14.1M
Q1 25
$-10.5M
$3.6M
Q4 24
$2.1M
$15.6M
Q3 24
$-2.9M
$11.0M
Q2 24
$-650.0K
$1.0M
Q1 24
$-7.3M
$11.2M
Free Cash Flow
LAW
LAW
PBYI
PBYI
Q4 25
$255.0K
$14.4M
Q3 25
$-2.0M
$9.7M
Q2 25
$-5.2M
$14.1M
Q1 25
$-11.0M
$3.6M
Q4 24
$1.5M
$15.6M
Q3 24
$-3.7M
$11.0M
Q2 24
$-1.3M
$1.0M
Q1 24
$-8.0M
FCF Margin
LAW
LAW
PBYI
PBYI
Q4 25
0.6%
19.1%
Q3 25
-5.0%
17.7%
Q2 25
-13.6%
26.8%
Q1 25
-30.1%
7.7%
Q4 24
4.1%
26.4%
Q3 24
-10.3%
13.7%
Q2 24
-3.6%
2.1%
Q1 24
-22.5%
Capex Intensity
LAW
LAW
PBYI
PBYI
Q4 25
1.2%
0.0%
Q3 25
2.6%
0.0%
Q2 25
2.5%
0.0%
Q1 25
1.4%
0.1%
Q4 24
1.5%
0.0%
Q3 24
2.4%
0.0%
Q2 24
1.8%
0.0%
Q1 24
1.9%
0.0%
Cash Conversion
LAW
LAW
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LAW
LAW

Software$35.1M85%
Services$6.0M15%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons